Gábor Heltovics

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.